Ovid Therapeutics Inc (OVID) Stock Analysis

Ovid Therapeutics Inc (OVID) is a publicly traded company in the HEALTHCARE sector. It trades at $2.40, carries a market capitalization of $477.80M. This page summarizes the public market data, fundamentals, and frequently asked questions for OVID, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Ovid Therapeutics Inc currently has a Bullish sentiment score of 0.16.

About Ovid Therapeutics Inc

Ovid Therapeutics Inc. is a biopharmaceutical company based in New York, dedicated to creating innovative therapies for patients and families affected by neurological disorders. The firm focuses on developing impactful medications with a strong emphasis on addressing unmet medical needs in this complex and under-researched area. With a robust pipeline of product candidates, Ovid positions itself as a leader in advancing treatments that aim to improve the quality of life for patients suffering...

GNG Research Analysis

GNG Research scores Ovid Therapeutics Inc (OVID) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for OVID.

Frequently Asked Questions

Does OVID pay dividends?

Ovid Therapeutics Inc (OVID) does not currently pay a regular dividend.

What is OVID's market cap?

Ovid Therapeutics Inc (OVID) has a market capitalization of $477.80M with a current stock price of $2.40.